Adam Hutchings

• Combination Therapies
• Value-Based Pricing

A Framework for Value-aligned Pricing of Combination Therapies

Read more

• Diagnostics and Imaging
• Takeda
• Precision Medicine

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

Read more

• HTA
• PhRMA
• Health Technology Assessment…

How is Quality of Life Measured for Health Technology Assessments?

Read more

• Clinical Outcomes
• EuroQol

Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation?

Read more

• Biogen
• Clinical Outcomes
• Muscoloskeletal
• Rare and Orphan Diseases

How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy

Read more